Αποτελέσματα Αναζήτησης
of stroke was attributable to modifiable risk factors.6 A modeling study showed that targeting multiple risk factors has additive benefits for secondary prevention; specifically, aspirin, statin, and antihypertensive medi-cations, combined with diet modification and exercise, can result in an 80% cumulative risk reduction in recur-
24 Μαΐ 2021 · In the WASID trial (Warfarin-Aspirin Symptomatic Intracranial Disease), warfarin (target INR, 2–3) compared with aspirin 650 mg twice a day was found to have a higher rate of major hemorrhages (relative difference, 5.1%) and all-cause death (relative difference, 5.4%) but did not prevent more primary end points (stroke, ICH, vascular death ...
1 Απρ 1996 · Background A vast consensus exists in defining a narrow range of recommended daily doses of aspirin, ie, 75 to 160 mg, for the prevention of myocardial infarction, stroke, and vascular death in patients with different manifestations of coronary heart disease.
consider aspirin therapy (81 mg daily or 100 mg every other day) if blood pressure is controlled and benefit for ischemic stroke and MI prevention is likely to outweigh risk of gastrointestinal bleeding and hemorrhagic stroke (Class IIa, Level B) and in women <65 years of age when benefit for ischemic stroke prevention is likely to outweigh ...
2 Ιουν 2021 · For most ischemic stroke patients, there is no role for long-term dual antiplatelet therapy with the combination of aspirin and clopidogrel. Short-term dual antiplatelet treatment is recommended in selected patients with symptomatic intracranial atherosclerotic disease or with minor stroke or TIA.
“Low-dose aspirin might be considered for primary prevention of ASCVD in select higher ASCVD adults aged 40-70 years who are not at increased bleeding risk; Low-dose aspirin should not be administered on a routine basis for primary prevention of ASCVD among adults > 70 years.
2 Αυγ 2019 · Based on these results, in 2016, the USPSTF recommended the use of low-dose aspirin for adults aged 50 to 59 years with a 10-year CVD risk ≥10%, not at increased risk of bleeding, a life expectancy of ≥10 years, and willing to take low-dose aspirin daily for ≥10 years. For
